This study identifies two key cellular responses to metabolic dysfunction in the context of AD: a shared glial MinD transcriptional program and the selective upregulation of Meis2 in cortical L2 inhibitory neurons. This evidence concerns the gene MEIS2 and Alzheimer disease.